Growth Accelerated By Rising Demand For Safe Abortion Procedures
Abortion Drugs Market |
Abortion drugs are medications
used to induce an abortion. The most common abortion drugs used are
mifepristone and misoprostol. Mifepristone blocks the hormone progesterone,
which is needed to sustain a pregnancy. Misoprostol causes contractions and
helps in expelling the pregnancy from the uterus. These drugs provide a
non-surgical option for abortion which is safer than traditional methods and
allows women to terminate a pregnancy privately. With the rise in unwanted
pregnancies globally due to lack of sexual education and access to
contraceptives in developing nations, the demand for safe abortion drugs and
procedures is growing rapidly. The global Abortion Drugs Market is estimated to
be valued at US$ 3.53 Bn in 2023 and is expected to exhibit a CAGR of 10% over
the forecast period 2023 to 2030, as highlighted in a new report published by
Coherent Market Insights.
Market key trends:
The growing demand for
non-surgical abortion methods has accelerated the use of medical abortion drugs
significantly over the past decade. According to the World Health Organization,
close to 30% of all induced abortions conducted globally use medical abortion
pills. Mifepristone combined with misoprostol has become the gold standard
non-surgical regimen for early medical abortions. Its effectiveness is around
95-98% when used within the first trimester of pregnancy. With increasing
awareness about women's reproductive healthcare globally, more women now prefer
a medical abortion over surgical procedures as it provides privacy and avoids
invasive treatments. This trend towards non-surgical abortions has boosted the
growth of the overall abortion drugs market over the past few years.
Segment Analysis
The global abortion drugs market
is segmented into age group, product type, and region. By age group, the market
is bifurcated into under 15 years and 15-24 years. The 15-24 years segment
dominated the market in 2023 and is projected to witness highest growth during
the forecast period. This is mainly due to increasing unwanted pregnancies and
abortion rates among women belonging to this age group.
By product type, the market is
classified into mifepristone, misoprostol, and other drugs. The misoprostol
segment accounted for the largest share of the global abortion drugs market in
2023. This is attributed to factors such as efficacy and lower costs of
misoprostol as compared to other drugs.
Key Takeaways
The Global
Abortion Drugs Market Size is expected to witness high growth during
the forecast period of 2023 to 2030. The market size for 2023 is US$ 3.53 Bn
and is projected to reach US$ 6.1 Bn by 2030, expanding at a CAGR of 10%.
Regional analysis - North America dominated the global abortion
drugs market in 2023 and is expected to maintain its leading position
throughout the forecast period. This is attributed to easy access and
availability of abortion drugs, and acceptance of abortion in countries like the
U.S. Asia Pacific is projected to witness fastest growth, due to increasing
awareness regarding abortion rights and services in emerging countries like
India.
Key players - Key players operating in the abortion drugs market
are IBM Corporation, Hewlett Packard Enterprise, Infosys Limited, Wipro
Limited, Capgemini SE, Cognizant Technology Solutions Corporation, TATA
Consultancy Services Limited, Deloitte Touche Tohmatsu Limited, Accenture plc,
PAREXEL International Corporation, PwC International Limited, IQVIA Holdings
Inc., Tata Technologies Limited, Computer Sciences Corporation (CSC), Eurofins
Scientific SE. These players are focusing on new product development and
regional expansion strategies to strengthen their market position.
Get More Insights Here
https://www.newsstatix.com/abortion-drugs-market-share-size-forecast-outlook-2023-2030-2/
Comments
Post a Comment